| Literature DB >> 31640600 |
Katherine Grady1, Martin Gibson2, Peter Bower3.
Abstract
BACKGROUND: Recruitment to health research remains a major challenge. Innovation is required to meet policy commitments to help patients take part in health research. One innovation that may help meet those policy goals is the development of 'consent to contact' systems, where people give generic consent to be contacted about research opportunities. Despite their potential, there are few empirical assessments of different ways of recruiting patients to such communities, or of the value of such communities to local research teams. MAIN TEXT: We describe the development of the 'Research for the Future'consent to contact community, outline the recruitment of patients to the community, and present data on their participation in research. DISCUSSION: Over 5000 people have been registered across 3 clinical areas. A range of recruitment strategies have been used, including direct recruitment by clinicians, postal invitations from primary care, and social media. In a 1 year period (2016-2017), the community provided over 1500 participants for a variety of research projects. Feedback from research teams has generally been positive. The 'Research for the Future'consent to contact community has proven feasible and useful for local research teams. Further evaluation is needed to assess the cost-effectiveness of different recruitment strategies, explore patient and researcher experience of its advantages and disadvantages, and explore how the community can be more reflective of the wider population.Entities:
Keywords: Clinical trials; Data linkage; Electronic health records; Recruitment database
Year: 2019 PMID: 31640600 PMCID: PMC6805518 DOI: 10.1186/s12874-019-0843-4
Source DB: PubMed Journal: BMC Med Res Methodol ISSN: 1471-2288 Impact factor: 4.615
Fig. 1Recruitment into the community
Demographic details of people registered with the community
| Category | All patients | Diabetes | Respiratory | Heart disease |
|---|---|---|---|---|
| Gender | ||||
| Male | 2990 (53.5%) | |||
| Female | 2594 (46.4%) | |||
| Other | 3 (0.05%) | |||
| Age | ||||
| Mean age | 59.4 | 59.1 | 61.3 | 66.9 |
| Range | 18–98 | 18–96 | 22–89 | 19–96 |
| Conditiona | ||||
| Diabetes | 4960 | Type 1 28.0% ( | COPD 53.2% ( | Myocardial infarction 37.8% ( |
| Respiratory | 609 | Type 2 64.0% ( | Asthma 49.9% ( | Angina 27.5% ( |
| Heart | 468 | NDH 7.9% ( | Bronchiectasis 8.5% ( | Atrial Fibrillation 22.9% ( |
| Other 0.1% ( | Heart Failure 12.0% ( | |||
asome people are registered on more than one community
Research Interests of individuals in the community
| Research type | % | |
|---|---|---|
| Clinical trials –medical equipment | 5523 | 98.9 |
| Observational studies | 5307 | 95.0 |
| Questionnaires - postal | 5286 | 94.6 |
| Interviews – face to face | 5210 | 93.3 |
| Interviews – telephone | 5041 | 90.2 |
| Clinical trials –existing treatments | 5013 | 89.7 |
| Clinical trials – new treatments | 4981 | 89.2 |
| Focus Groups | 4836 | 86.6 |
| Questionnaires - electronic | 4400 | 78.8 |